ID   EF1G_HUMAN              Reviewed;         437 AA.
AC   P26641; B4DTG2; Q6PJ62; Q6PK31; Q96CU2; Q9P196;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 220.
DE   RecName: Full=Elongation factor 1-gamma;
DE            Short=EF-1-gamma;
DE   AltName: Full=eEF-1B gamma;
GN   Name=EEF1G; Synonyms=EF1G; ORFNames=PRO1608;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1461723; DOI=10.1093/nar/20.22.5907;
RA   Sanders J., Maassen J.A., Moeller W.;
RT   "Elongation factor-1 messenger-RNA levels in cultured cells are high
RT   compared to tissue and are not drastically affected further by oncogenic
RT   transformation.";
RL   Nucleic Acids Res. 20:5907-5910(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1598220; DOI=10.1093/nar/20.10.2598;
RA   Kumabe T., Schma Y., Yamamoto T.;
RT   "Human cDNAs encoding elongation factor 1 gamma and the ribosomal protein
RT   L19.";
RL   Nucleic Acids Res. 20:2598-2598(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, Eye, Liver, Lung, Muscle, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-14.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-14, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT
RP   ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (OCT-2004) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 80-437 (ISOFORM 1).
RC   TISSUE=Pancreatic carcinoma;
RX   PubMed=1372736; DOI=10.1097/00006676-199203000-00003;
RA   Lew Y., Jones D.V., Mars W.M., Evans D., Byrd D., Frazier M.L.;
RT   "Expression of elongation factor-1 gamma-related sequence in human
RT   pancreatic cancer.";
RL   Pancreas 7:144-152(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 121-437 (ISOFORM 1).
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Zhang Y., Zhou G., Bi J., Liu M., He F.;
RT   "Functional prediction of the coding sequences of 79 new genes deduced by
RT   analysis of cDNA clones from human fetal liver.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [11]
RP   INDUCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16548883; DOI=10.1111/j.1462-5822.2005.00644.x;
RA   Leong W.F., Chow V.T.;
RT   "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal
RT   differential cellular gene expression in response to enterovirus 71
RT   infection.";
RL   Cell. Microbiol. 8:565-580(2006).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-147 AND LYS-434, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   MALONYLATION AT LYS-434.
RX   PubMed=21908771; DOI=10.1074/mcp.m111.012658;
RA   Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y., He W.,
RA   Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C., Dai J.,
RA   Verdin E., Ye Y., Zhao Y.;
RT   "The first identification of lysine malonylation substrates and its
RT   regulatory enzyme.";
RL   Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-253, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-285, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [22]
RP   STRUCTURE BY NMR OF 276-437.
RX   PubMed=12766415; DOI=10.1023/a:1023504611632;
RA   Vanwetswinkel S., Kriek J., Andersen G.R., Dijk J., Siegal G.;
RT   "1H, 15N and 13C resonance assignments of the highly conserved 19 kDa C-
RT   terminal domain from human elongation factor 1Bgamma.";
RL   J. Biomol. NMR 26:189-190(2003).
CC   -!- FUNCTION: Probably plays a role in anchoring the complex to other
CC       cellular components.
CC   -!- SUBUNIT: EF-1 is composed of four subunits: alpha, beta, delta, and
CC       gamma.
CC   -!- INTERACTION:
CC       F4ZW62:-; NbExp=3; IntAct=EBI-10177695, EBI-10177680;
CC       P24534:EEF1B2; NbExp=6; IntAct=EBI-351467, EBI-354334;
CC       P29692:EEF1D; NbExp=4; IntAct=EBI-351467, EBI-358607;
CC       P29692-2:EEF1D; NbExp=3; IntAct=EBI-10177695, EBI-5280572;
CC       Q658K8:EEF1DP3; NbExp=4; IntAct=EBI-10177695, EBI-10248874;
CC       O94889:KLHL18; NbExp=3; IntAct=EBI-10177695, EBI-2510096;
CC       Q04695:KRT17; NbExp=2; IntAct=EBI-351467, EBI-297873;
CC       Q9HBL7:PLGRKT; NbExp=3; IntAct=EBI-10177695, EBI-714824;
CC       P78332:RBM6; NbExp=3; IntAct=EBI-10177695, EBI-2692323;
CC       Q969Q1:TRIM63; NbExp=2; IntAct=EBI-351467, EBI-5661333;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P26641-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P26641-2; Sequence=VSP_056204;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreatic tumor tissue and to
CC       a lesser extent in normal kidney, intestine, pancreas, stomach, lung,
CC       brain, spleen and liver.
CC   -!- INDUCTION: Down-regulated in response to enterovirus 71 (EV71)
CC       infection. {ECO:0000269|PubMed:16548883}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63526; CAA45089.1; -; mRNA.
DR   EMBL; Z11531; CAA77630.1; -; mRNA.
DR   EMBL; AK300203; BAG61974.1; -; mRNA.
DR   EMBL; AP001363; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP002990; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000384; AAH00384.1; -; mRNA.
DR   EMBL; BC006509; AAH06509.1; -; mRNA.
DR   EMBL; BC006520; AAH06520.1; -; mRNA.
DR   EMBL; BC007949; AAH07949.2; -; mRNA.
DR   EMBL; BC009865; AAH09865.1; -; mRNA.
DR   EMBL; BC013918; AAH13918.1; -; mRNA.
DR   EMBL; BC015813; AAH15813.1; -; mRNA.
DR   EMBL; BC021974; AAH21974.2; -; mRNA.
DR   EMBL; BC028179; AAH28179.1; -; mRNA.
DR   EMBL; BC031012; AAH31012.1; -; mRNA.
DR   EMBL; BC067738; AAH67738.1; -; mRNA.
DR   EMBL; M55409; AAC18414.1; -; mRNA.
DR   EMBL; AF119850; AAF69604.1; -; mRNA.
DR   CCDS; CCDS44626.1; -. [P26641-1]
DR   PIR; S22655; S22655.
DR   RefSeq; NP_001395.1; NM_001404.4. [P26641-1]
DR   PDB; 1PBU; NMR; -; A=276-437.
DR   PDB; 5DQS; X-ray; 2.10 A; A=2-218.
DR   PDB; 5JPO; X-ray; 2.00 A; A/B/C/D=1-218.
DR   PDBsum; 1PBU; -.
DR   PDBsum; 5DQS; -.
DR   PDBsum; 5JPO; -.
DR   SMR; P26641; -.
DR   BioGrid; 108257; 224.
DR   CORUM; P26641; -.
DR   DIP; DIP-32516N; -.
DR   IntAct; P26641; 185.
DR   MINT; P26641; -.
DR   STRING; 9606.ENSP00000331901; -.
DR   iPTMnet; P26641; -.
DR   PhosphoSitePlus; P26641; -.
DR   SwissPalm; P26641; -.
DR   BioMuta; EEF1G; -.
DR   DMDM; 119165; -.
DR   OGP; P26641; -.
DR   EPD; P26641; -.
DR   jPOST; P26641; -.
DR   MassIVE; P26641; -.
DR   PaxDb; P26641; -.
DR   PeptideAtlas; P26641; -.
DR   PRIDE; P26641; -.
DR   ProteomicsDB; 5107; -.
DR   ProteomicsDB; 54359; -. [P26641-1]
DR   TopDownProteomics; P26641-1; -. [P26641-1]
DR   DNASU; 1937; -.
DR   Ensembl; ENST00000329251; ENSP00000331901; ENSG00000254772. [P26641-1]
DR   GeneID; 1937; -.
DR   KEGG; hsa:1937; -.
DR   CTD; 1937; -.
DR   DisGeNET; 1937; -.
DR   GeneCards; EEF1G; -.
DR   HGNC; HGNC:3213; EEF1G.
DR   HPA; HPA040688; -.
DR   HPA; HPA055316; -.
DR   MIM; 130593; gene.
DR   neXtProt; NX_P26641; -.
DR   OpenTargets; ENSG00000254772; -.
DR   PharmGKB; PA27649; -.
DR   eggNOG; KOG0867; Eukaryota.
DR   eggNOG; KOG1627; Eukaryota.
DR   eggNOG; COG0625; LUCA.
DR   GeneTree; ENSGT00390000007552; -.
DR   HOGENOM; CLU_011226_3_1_1; -.
DR   InParanoid; P26641; -.
DR   KO; K03233; -.
DR   OMA; QIDYEVY; -.
DR   OrthoDB; 1341490at2759; -.
DR   PhylomeDB; P26641; -.
DR   TreeFam; TF314343; -.
DR   Reactome; R-HSA-156842; Eukaryotic Translation Elongation.
DR   ChiTaRS; EEF1G; human.
DR   EvolutionaryTrace; P26641; -.
DR   GeneWiki; EEF1G; -.
DR   GenomeRNAi; 1937; -.
DR   Pharos; P26641; Tdark.
DR   PRO; PR:P26641; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P26641; protein.
DR   Bgee; ENSG00000254772; Expressed in muscle of leg and 88 other tissues.
DR   ExpressionAtlas; P26641; baseline and differential.
DR   Genevisible; P26641; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0009615; P:response to virus; IEP:UniProtKB.
DR   GO; GO:0006414; P:translational elongation; IBA:GO_Central.
DR   Gene3D; 3.30.70.1010; -; 1.
DR   Gene3D; 3.40.30.10; -; 1.
DR   InterPro; IPR001662; EF1B_G_C.
DR   InterPro; IPR036433; EF1B_G_C_sf.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR040079; Glutathione_S-Trfase.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR004046; GST_C.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   Pfam; PF00647; EF1G; 1.
DR   Pfam; PF00043; GST_C; 1.
DR   Pfam; PF02798; GST_N; 1.
DR   SFLD; SFLDS00019; Glutathione_Transferase_(cytos; 1.
DR   SMART; SM01183; EF1G; 1.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   SUPFAM; SSF89942; SSF89942; 1.
DR   PROSITE; PS50040; EF1G_C; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
DR   PROSITE; PS50404; GST_NTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Direct protein sequencing;
KW   Elongation factor; Isopeptide bond; Protein biosynthesis;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000269|PubMed:12665801, ECO:0000269|Ref.7"
FT   CHAIN           2..437
FT                   /note="Elongation factor 1-gamma"
FT                   /id="PRO_0000208813"
FT   DOMAIN          2..87
FT                   /note="GST N-terminal"
FT   DOMAIN          88..216
FT                   /note="GST C-terminal"
FT   DOMAIN          276..437
FT                   /note="EF-1-gamma C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00519"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000269|Ref.7"
FT   MOD_RES         147
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         212
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D8N0"
FT   MOD_RES         401
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D8N0"
FT   MOD_RES         434
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         434
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21908771"
FT   CROSSLNK        253
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        285
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..4
FT                   /note="MAAG -> MAERWVAPAVLRRARFASTFFLSPQIYAHKDGDLRSAFFILSFK
FT                   RGEFIPFLNW (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056204"
FT   CONFLICT        102
FT                   /note="A -> V (in Ref. 5; AAH13918)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..7
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           13..25
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   STRAND          28..32
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   TURN            35..37
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   TURN            40..42
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           43..45
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           47..52
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   STRAND          58..63
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           72..78
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           82..85
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           89..105
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           107..117
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           125..145
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   TURN            146..148
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   STRAND          150..153
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           159..174
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           178..181
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           185..195
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           198..204
FT                   /evidence="ECO:0000244|PDB:5JPO"
FT   HELIX           279..281
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           290..299
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           302..304
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           306..311
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   TURN            316..318
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   STRAND          320..324
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           329..331
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           338..348
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           349..351
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           353..355
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   STRAND          356..358
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   STRAND          361..364
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   STRAND          370..381
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           384..386
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           388..390
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           394..396
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   HELIX           408..418
FT                   /evidence="ECO:0000244|PDB:1PBU"
FT   TURN            424..426
FT                   /evidence="ECO:0000244|PDB:1PBU"
SQ   SEQUENCE   437 AA;  50119 MW;  A6110663110CF3FC CRC64;
     MAAGTLYTYP ENWRAFKALI AAQYSGAQVR VLSAPPHFHF GQTNRTPEFL RKFPAGKVPA
     FEGDDGFCVF ESNAIAYYVS NEELRGSTPE AAAQVVQWVS FADSDIVPPA STWVFPTLGI
     MHHNKQATEN AKEEVRRILG LLDAYLKTRT FLVGERVTLA DITVVCTLLW LYKQVLEPSF
     RQAFPNTNRW FLTCINQPQF RAVLGEVKLC EKMAQFDAKK FAETQPKKDT PRKEKGSREE
     KQKPQAERKE EKKAAAPAPE EEMDECEQAL AAEPKAKDPF AHLPKSTFVL DEFKRKYSNE
     DTLSVALPYF WEHFDKDGWS LWYSEYRFPE ELTQTFMSCN LITGMFQRLD KLRKNAFASV
     ILFGTNNSSS ISGVWVFRGQ ELAFPLSPDW QVDYESYTWR KLDPGSEETQ TLVREYFSWE
     GAFQHVGKAF NQGKIFK
//
